Thermo Fisher Scientific Inc. closed 8.73% below its 52-week high of $627.88, which the company reached on September 10th.

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Ameritas Advisory Services LLC reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 19.8% during ...

Respiratory disease testing companies are Koninklijke Philips N.V., Niterra., Thermo Fisher Scientific, QIAGEN, Abbott, Danaher Corp, Siemens Healthineers, etc ...

An interview on how advanced techniques can be used to enhance silk fibroin and chitosan for drug delivery applications.

Culture Biosciences, a leader in cloud-connected bioprocessing technologies, is pleased to announce the appointment of Victor Bornsztejn as the company’s new Senior Vice President of Commercial. In ...

The expanding scope of nuclear medicine has driven the demand for irradiation equipment that ensures high precision in ...

The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.

Enverus, the most trusted energy-dedicated SaaS company that leverages generative AI across its solutions, is releasing its 2025 Global Energy Outlook, an e-book focused on pivotal North American and ...

Institute for Supply Management® (ISM®) announces the retirement of Esteemed Timothy R. Fiore, who has served as the Chair of ISM's Manufacturing PMI® Panel since 2017. Fiore will be succeeded by ...

Advanced technologies like XRF, OES, and PAT optimize steel production by improving raw material usage, process efficiency, ...

The global at-home micronutrient testing market is poised for significant growth, with the market size estimated at USD 297.5 ...